胎盘细胞外囊泡相关microRNA-519c介导妊娠内毒素适应
本研究探讨胎盘特异性microRNA-519c在内毒素耐受中的作用。胎盘外植体重复脂多糖刺激后出现耐受表型,即肿瘤坏死因子α降低、白细胞介素10升高,该反应由胎盘细胞外囊泡内microRNA-519c介导,其通过下调磷酸二酯酶3B抑制肿瘤坏死因子α产生;炎症相关妊娠胎盘microRNA-519c水平降低。
要点
- 胎盘重复内毒素刺激诱导耐受表型:肿瘤坏死因子α降低、白细胞介素10升高。
- microRNA-519c经胎盘细胞外囊泡介导抗炎,下调磷酸二酯酶3B抑制肿瘤坏死因子α。
- 炎症相关妊娠胎盘microRNA-519c水平降低,或可作为感染所致早产标志物。
核心结论
- microRNA-519c是人胎盘特异性microRNA,为母胎界面感染诱导早产相关免疫适应的新调节因子。
研究设计与样本
- 使用足月及中孕期胎盘外植体培养,脂多糖处理24小时后收集条件培养基,并重复暴露脂多糖3天。
- 检测上清炎症标志物、细胞外囊泡及microRNA,并用microRNA模拟物和磷酸二酯酶3B小干扰RNA转染研究机制。
- 分析不同孕龄及炎症相关妊娠的人胎盘样本。
主要发现
- 重复脂多糖刺激人胎盘诱导耐受表型,表现为肿瘤坏死因子α降低和白细胞介素10上调。
- 脂多糖增加CD9、CD63、CD81阳性的细胞外囊泡,主要由滋养细胞分泌。
- 转染microRNA-519c模拟物降低磷酸二酯酶3B,而磷酸二酯酶3B缺失导致肿瘤坏死因子α产生减少。
- 正常及炎症相关妊娠人胎盘显示,胎盘microRNA-519c水平降低与感染诱导的妊娠炎症病理相关。
临床怎么用
- 提示microRNA-519c可能作为感染诱导早产的候选生物标志物,但尚需未来实验验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pregnancy represents a unique challenge for the maternal-fetal immune interface, requiring a balance between immunosuppression, which is essential for the maintenance of a semiallogeneic fetus, and proinflammatory host defense to protect the maternal-fetal interface from invading organisms. Adaptation to repeated inflammatory stimuli (endotoxin tolerance) may be critical in preventing inflammation-induced preterm birth caused by exaggerated maternal inflammatory responses to mild or moderate infections that are common during pregnancy. However, the exact mechanisms contributing to the maintenance of tolerance to repeated infections are not completely understood. MicroRNAs play important roles in pregnancy with several microRNAs implicated in gestational tissue function and in pathologic pregnancy conditions. MicroRNA-519c, a member of the chromosome 19 microRNA cluster, is a human-specific microRNA mainly expressed in the placenta. However, its role in pregnancy is largely unknown. OBJECTIVE: This study aimed to explore the role of "endotoxin tolerance" failure in the pathogenesis of an exaggerated inflammatory response often seen in inflammation-mediated preterm birth. In this study, we investigated the role of microRNA-519c, a placenta-specific microRNA, as a key regulator of endotoxin tolerance at the maternal-fetal interface. STUDY DESIGN: Using a placental explant culture system, samples from term and second-trimester placentas were treated with lipopolysaccharide. After 24 hours, the conditioned media were collected for analysis, and the placental explants were re-exposed to repeated doses of lipopolysaccharide for 3 days. The supernatant was analyzed for inflammatory markers, the presence of extracellular vesicles, and microRNAs. To study the possible mechanism of action of the microRNAs, we evaluated the phosphodiesterase 3B pathway involved in tumor necrosis factor alpha production using a microRNA mimic and phosphodiesterase 3B small interfering RNA transfection. Finally, we analyzed human placental samples from different gestational ages and from women affected by inflammation-associated pregnancies. RESULTS: Our data showed that repeated exposure of the human placenta to endotoxin challenges induced a tolerant phenotype characterized by decreased tumor necrosis factor alpha and up-regulated interleukin-10 levels. This reaction was mediated by the placenta-specific microRNA-519c packaged within placental extracellular vesicles. Lipopolysaccharide treatment increased the extracellular vesicles that were positive for the exosome tetraspanin markers, namely CD9, CD63, and CD81, and secreted primarily by trophoblasts. Primary human trophoblast cells transfected with a microRNA-519c mimic decreased phosphodiesterase 3B, whereas a lack of phosphodiesterase 3B, achieved by small interfering RNA transfection, led to decreased tumor necrosis factor alpha production. These data support the hypothesis that the anti-inflammatory action of microRNA-519c was mediated by a down-regulation of the phosphodiesterase 3B pathway, leading to inhibition of tumor necrosis factor alpha production. Furthermore, human placentas from normal and inflammation-associated pregnancies demonstrated that a decreased placental microRNA-519c level was linked to infection-induced inflammatory pathologies during pregnancy. CONCLUSION: We identified microRNA-519c, a human placenta-specific microRNA, as a novel regulator of immune adaptation associated with infection-induced preterm birth at the maternal-fetal interface. Our study serves as a basis for future experiments to explore the potential use of microRNA-519c as a biomarker for infection-induced preterm birth.
引用
- Tiozzo C, Bustoros M, Lin X, et al. Placental extracellular vesicles-associated microRNA-519c mediates endotoxin adaptation in pregnancy. Am J Obstet Gynecol. 2021. PMID: 34181894. doi:10.1016/j.ajog.2021.06.075
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。